What is Boehringer Ingelheims engagement and commitment?
As an innovative pharmaceutical company, Boehringer Ingelheim has a large and experienced global team managing and conducting clinical trials in many indications around the world. Such trials are conducted to establish the potential of drugs under investigation to progress to becoming new medicines. With these trials we evaluate the safety, tolerability and efficacy of drugs. They are fundamental to developing novel treatments of therapeutic benefit. Patient safety is the prime concern of Boehringer Ingelheim when designing clinical trials. Our trials are conducted according to agreed international standards and in compliance with all respective regulations. All patients who enter into our clinical trials are fully informed about potential risks and the benefits of their involvement and are free to withdraw their consent or discontinue participation at any time with no need for justification.
